Table 3: Antibiogram of bacterial isolates from Surgical wound infections.
Selected antibiotic |
E-coli |
Klebsiella |
Pseudomonas |
Acinetobacter baumanii |
Staph |
Enterococcus fecalis |
||
S. aureus |
CONS |
|||||||
|
47 |
21.3% |
- |
- |
33.3 |
30 |
10 |
|
Oxacillin/Cloxacillin |
- |
- |
- |
- |
72 |
67 |
- |
|
Clindamycin |
- |
- |
- |
- |
75 |
62.2 |
10 |
|
Gentamicin |
61 |
50 |
84 |
60 |
92 |
88 |
45 |
|
Tetracycline |
- |
- |
- |
- |
93 |
100 |
100 |
|
Amikacin |
66.6 |
50.9 |
91 |
- |
- |
- |
- |
|
Ampicillin/Sulbactam |
61 |
77.1 |
- |
60 |
- |
- |
- |
|
Piperacillin/tazobactam |
65 |
57.1 |
54.5 |
46 |
- |
- |
- |
|
Ciprofloxacin |
59.1 |
37.5 |
48.5 |
11.5 |
50 |
53 |
53 |
|
Levofloxacin |
54.6 |
32.2 |
54 |
12.1 |
61.1 |
56 |
54 |
|
3rd generation Cephalosporins Ceftazidime & Ceftriaxone |
47.9 |
47.1 |
21.2 |
20 |
- |
- |
- |
|
4th generation Cephalosporins: Cefepime |
51.7 |
53.6 |
33.3 |
24 |
- |
- |
- |
|
Erythromycin |
- |
- |
- |
- |
30.8 |
44 |
19.6 |
|
Vancomycin |
- |
- |
- |
- |
92 |
100 |
79 |
|
Meropenem |
88 |
79.5 |
79 |
58.7 |
- |
- |
- |
|
Linezolid |
- |
- |
- |
- |
100 |
100 |
100 |
• Not all isolates tested against every antibiotic listed
• CONS: coagulase negative staphylococci
• Vitek2 system includes an advanced expert system (AES) that analyzes MIC patterns and detects phenotypes for most organisms tested. The AES also deduces susceptibility to drugs not tested based on antimicrobial phenotype of the strain